SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-22-107780
Filing Date
2022-10-11
Accepted
2022-10-11 17:21:46
Documents
12

Document Format Files

Seq Description Document Type Size
1 S-3 tm2227556-1_s3.htm S-3 423522
2 EXHIBIT 4.3 tm2227556d2_ex4-3.htm EX-4.3 395909
3 EXHIBIT 4.5 tm2227556d2_ex4-5.htm EX-4.5 111609
4 EXHIBIT 4.6 tm2227556d2_ex4-6.htm EX-4.6 123877
5 EXHIBIT 4.7 tm2227556d2_ex4-7.htm EX-4.7 101628
6 EXHIBIT 5.1 tm2227556d2_ex5-1.htm EX-5.1 29175
7 EXHIBIT 23.1 tm2227556d2_ex23-1.htm EX-23.1 2299
8 EXHIBIT 23.2 tm2227556d2_ex23-2.htm EX-23.2 2773
9 EXHIBIT 23.3 tm2227556d2_ex23-3.htm EX-23.3 2167
10 EX-FILING FEES tm2227556d2_ex-filingfees.htm EX-FILING FEES 67210
11 GRAPHIC lg_egalepharamc-4clr.jpg GRAPHIC 35696
12 GRAPHIC tm2227556d2_ex5-1img001.jpg GRAPHIC 8044
  Complete submission text file 0001104659-22-107780.txt   1321810
Mailing Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BOULEVARD, SUITE 315 WOODCLIFF LAKE NJ 07677 201-326-5300
EAGLE PHARMACEUTICALS, INC. (Filer) CIK: 0000827871 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-267827 | Film No.: 221304827
SIC: 2834 Pharmaceutical Preparations